Nasal 'Molecular Shield' Promises New Hope for Hay Fever Relief
Researchers have developed a 'molecular shield' using monoclonal antibodies that can intercept mugwort pollen allergens in the nose, showing promising results in mice and potentially offering a new, non-invasive way to prevent allergy symptoms in humans in the future.